LEXICON PHARMACEUTICALS, INC. Insider Trading for March 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LEXICON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LEXICON PHARMACEUTICALS, INC. for March 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 2,797 | 0 | 8,393 | |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 4,495 | 0 | 8,990 | |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 5,807 | 0 | 5,807 | |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 2,929 | 0 | 0 | |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Payment of Exercise | F | 8.53 | 6,133 | 52,314 | 59,492 | 65.6 K to 59.5 K (-9.35 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 2,797 | 0 | 65,625 | 62.8 K to 65.6 K (+4.45 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 4,495 | 0 | 62,828 | 58.3 K to 62.8 K (+7.71 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 5,807 | 0 | 58,333 | 52.5 K to 58.3 K (+11.06 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 2,929 | 0 | 52,526 | 49.6 K to 52.5 K (+5.91 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 2,990 | 0 | 8,970 | |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Payment of Exercise | F | 8.53 | 728 | 6,210 | 2,262 | 3 K to 2.3 K (-24.35 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 2,990 | 0 | 2,990 | 0 to 3 K |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 1,270 | 0 | 3,810 | |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 2,075 | 0 | 4,150 | |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 2,668 | 0 | 2,668 | |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 1,340 | 0 | 0 | |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Payment of Exercise | F | 8.53 | 1,805 | 15,397 | 25,643 | 27.4 K to 25.6 K (-6.58 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 1,270 | 0 | 27,448 | 26.2 K to 27.4 K (+4.85 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 2,075 | 0 | 26,178 | 24.1 K to 26.2 K (+8.61 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 2,668 | 0 | 24,103 | 21.4 K to 24.1 K (+12.45 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 1,340 | 0 | 21,435 | 20.1 K to 21.4 K (+6.67 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Option Exercise | M | 0.00 | 2,592 | 0 | 7,778 | |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Option Exercise | M | 0.00 | 2,353 | 0 | 4,705 | |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Payment of Exercise | F | 8.53 | 1,652 | 14,092 | 4,552 | 6.2 K to 4.6 K (-26.63 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Buy | M | 0.00 | 2,592 | 0 | 6,204 | 3.6 K to 6.2 K (+71.76 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Buy | M | 0.00 | 2,353 | 0 | 3,612 | 1.3 K to 3.6 K (+186.89 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Option Exercise | M | 0.00 | 2,497 | 0 | 7,493 | |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Option Exercise | M | 0.00 | 4,085 | 0 | 8,170 | |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Option Exercise | M | 0.00 | 5,272 | 0 | 5,271 | |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Option Exercise | M | 0.00 | 2,679 | 0 | 0 | |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Payment of Exercise | F | 8.53 | 4,962 | 42,326 | 53,801 | 58.8 K to 53.8 K (-8.44 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Buy | M | 0.00 | 2,497 | 0 | 58,763 | 56.3 K to 58.8 K (+4.44 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Buy | M | 0.00 | 4,085 | 0 | 56,266 | 52.2 K to 56.3 K (+7.83 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Buy | M | 0.00 | 5,272 | 0 | 52,181 | 46.9 K to 52.2 K (+11.24 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Buy | M | 0.00 | 2,679 | 0 | 46,909 | 44.2 K to 46.9 K (+6.06 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 2,585 | 0 | 7,755 | |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 4,228 | 0 | 8,455 | |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 4,550 | 0 | 4,550 | |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 2,821 | 0 | 0 | |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Payment of Exercise | F | 8.53 | 4,822 | 41,132 | 33,975 | 38.8 K to 34 K (-12.43 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 2,585 | 0 | 38,797 | 36.2 K to 38.8 K (+7.14 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 4,228 | 0 | 36,212 | 32 K to 36.2 K (+13.22 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 4,550 | 0 | 31,984 | 27.4 K to 32 K (+16.59 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 2,821 | 0 | 27,434 | 24.6 K to 27.4 K (+11.46 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | M | 0.00 | 5,362 | 0 | 16,088 | |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | M | 0.00 | 8,390 | 0 | 16,780 | |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | M | 0.00 | 10,836 | 0 | 10,835 | |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Payment of Exercise | F | 8.53 | 9,494 | 80,984 | 58,079 | 67.6 K to 58.1 K (-14.05 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | M | 0.00 | 5,362 | 0 | 67,573 | 62.2 K to 67.6 K (+8.62 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | M | 0.00 | 8,390 | 0 | 62,211 | 53.8 K to 62.2 K (+15.59 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | M | 0.00 | 10,836 | 0 | 53,821 | 43 K to 53.8 K (+25.21 %) |